← Leaderboards
Robert N Weinreb
University Of California, San Diego
$22,653,673
Attributed
$26,870,665
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,870,665 · 8
By mechanism
R01$17,604,212 · 5
U10$4,999,185 · 2
K12$4,267,268 · 1
Top collaborators
- Jerome I. Rotter5 shared
- Todd P Coleman4 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Jeffrey S. Grethe$3,591,458
- Sally Liu Baxter$4,664,522
- Todd P Coleman$3,849,697
- Scott T Weiss$73,772,324
Others in their field
Top investigators on “Glaucoma”
- Rohit Varma · University Of Southern California$58,233,961
- Janey L Wiggs · Massachusetts Eye And Ear Infirmary$36,083,461
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- David Huang · Cleveland Clinic Lerner Col/Med-Cwru$27,740,623
- Linda M Zangwill · University Of California San Diego$23,025,291
- Michael A Kass · Washington University$21,080,537
Research focus
GlaucomaAreaVisual FieldsLeadAfrican AmericanStructureMinorityRetinaDiagnosisBlindnessThickBaseOptic DiskDesignMonitorCaliforniaOptic NerveClinical TrialsGlaucoma TestUniversitiesIntraocular PressurePredictive ModelingComplexDisease Progression
Grant awards (57)
Ophthalmology and Visual Sciences Career Development K12 Program$1
K12 · FY2025 · EY · contact PI
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography$691,680
R01 · FY2024 · EY · contact PI
iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities$509,187
R01 · FY2024 · MD · contact PI
Ophthalmology and Visual Sciences Career Development K12 Program$493,372
K12 · FY2024 · EY · contact PI
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography$104,109
R01 · FY2024 · EY · contact PI
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography$691,680
R01 · FY2023 · EY · contact PI
iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities$529,627
R01 · FY2023 · MD · contact PI
Ophthalmology and Visual Sciences Career Development K12 Program$493,372
K12 · FY2023 · EY · contact PI
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography$695,630
R01 · FY2022 · EY · contact PI
iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities$526,424
R01 · FY2022 · MD · contact PI
Ophthalmology and Visual Sciences Career Development K12 Program$493,372
K12 · FY2022 · EY · contact PI
iGLAMOUR Study: Innovations in Glaucoma Adherence and monitoring Of Under-Represented minorities$542,012
R01 · FY2021 · MD · contact PI
Ophthalmology and Visual Sciences Career Development K12 Program$493,372
K12 · FY2021 · EY · contact PI
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography$489,850
R01 · FY2021 · EY · contact PI
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography$503,669
R01 · FY2020 · EY · contact PI
Ophthalmology and Visual Sciences Career Development K12 Program$512,686
K12 · FY2019 · EY · contact PI
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography$503,403
R01 · FY2019 · EY · contact PI
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography Angiography$508,595
R01 · FY2018 · EY · contact PI
Ophthalmology and Visual Sciences Career Development K12 Program$474,406
K12 · FY2018 · EY · contact PI
xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans$1,135,810
R01 · FY2017 · EY · contact PI
Ophthalmology and Visual Sciences Career Development K12 Program$640,174
K12 · FY2017 · EY · contact PI
xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans$1,145,502
R01 · FY2016 · EY · contact PI
Ophthalmology and Visual Sciences Career Development K12 Program$439,788
K12 · FY2016 · EY · contact PI
xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans$1,056,858
R01 · FY2015 · EY · contact PI
Ophthalmology and Visual Sciences Career Development K12 Program$226,725
K12 · FY2015 · EY · contact PI
xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans$1,410,750
R01 · FY2014 · EY · contact PI
xADAGES III: Contribution of genotype to glaucoma phenotype in African Americans$1,577,815
R01 · FY2013 · EY · contact PI
Sirtuins in Glaucomatous Optic Neuropathy$596,036
R01 · FY2013 · EY · contact PI
Sirtuins in Glaucomatous Optic Neuropathy$639,587
R01 · FY2012 · EY · contact PI
Sirtuins in Glaucomatous Optic Neuropathy$595,772
R01 · FY2011 · EY · contact PI
Quantitative Analysis of Optic Disc/Ocular Hypertension$386,250
U10 · FY2009 · EY · contact PI
Eicosanoids and the Outflow Pathways of the Eye$423,814
R01 · FY2008 · EY · contact PI
Quantitative Analysis of Optic Disc/Ocular Hypertension$386,250
U10 · FY2008 · EY · contact PI
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$127,599
U10 · FY2008 · EY · contact PI
Eicosanoids and the Outflow Pathways of the Eye$421,192
R01 · FY2007 · EY · contact PI
Quantitative Analysis of Optic Disc/Ocular Hypertension$386,250
U10 · FY2007 · EY · contact PI
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$124,906
U10 · FY2007 · EY · contact PI
Eicosanoids and the Outflow Pathways of the Eye$486,449
R01 · FY2006 · EY · contact PI
Quantitative Analysis of Optic Disc/Ocular Hypertension$386,250
U10 · FY2006 · EY · contact PI
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$122,287
U10 · FY2006 · EY · contact PI
Eicosanoids and the Outflow Pathways of the Eye$514,609
R01 · FY2005 · EY
Quantitative Analysis of Optic Disc/Ocular Hypertension$385,000
U10 · FY2005 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$119,745
U10 · FY2005 · EY
Eicosanoids and the Outflow Pathways of the Eye$434,510
R01 · FY2004 · EY
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION$379,319
U10 · FY2004 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$117,278
U10 · FY2004 · EY
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION$368,410
U10 · FY2003 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$180,735
U10 · FY2003 · EY
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION$357,680
U10 · FY2002 · EY
EICOSANOIDS IN THE OUTFLOW PATHWAYS OF THE EYE$290,044
R01 · FY2002 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$176,177
U10 · FY2002 · EY
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION$347,264
U10 · FY2001 · EY
EICOSANOIDS IN THE OUTFLOW PATHWAYS OF THE EYE$285,353
R01 · FY2001 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$150,500
U10 · FY2001 · EY
QUANTITATIVE ANALYSIS OF OPTIC DISC/OCULAR HYPERTENSION$350,459
U10 · FY2000 · EY
EICOSANOIDS IN THE OUTFLOW PATHWAYS OF THE EYE$294,245
R01 · FY2000 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$146,826
U10 · FY2000 · EY